Molecular approaches in the diagnosis of primary immunodeficiency diseases

被引:16
作者
Costabile, Maurizio
Quach, Alex
Ferrante, Antonio
机构
[1] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia
[2] Childrens Youth & Womens Hlth Serv S Australia, Dept Immunopathol, Adelaide, SA, Australia
[3] Childrens Youth & Womens Hlth Serv S Australia, Dept Paediat, Adelaide, SA, Australia
关键词
immunology; immunogenetics; primary immunodeficiency diseases; mutation detection; dideoxy sequencing; resequencing; SNP detection;
D O I
10.1002/humu.20412
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Over 120 inherited primary immunodeficiency diseases (PIDs) are known to exist. The genes responsible for many of these diseases have also been identified. Recent advances in diagnostic procedures have enabled these to be identified earlier and appropriately treated. While a number of approaches are available to identify mutations, direct sequencing remains the gold standard. This approach identifies the exact genetic change with substantial precision. We suggest that a sensitive and economical approach to mutation detection could be the direct sequencing of cDNA followed by the confirmatory sequencing of the corresponding exon. While screening techniques such as single-stranded conformation polymorphism (SSCP), heteroduplex analysis (RA), denaturing gradient gel electrophoresis (DGGE), and denaturing high,performance liquid chromatography (dHPLC) have proven useful, each has inherent advantages and disadvantages. We discuss these advantages and disadvantages and also discuss the potential of future sequencing technologies such as pyrosequencing, combinatorial sequencing,by-hybridization, multiplex polymerase colony (polony), and resequencing arrays as tools for future mutation detection. In addition we briefly discuss several high-throughput SNP detection technologies.
引用
收藏
页码:1163 / 1173
页数:11
相关论文
共 85 条
[1]   Pyrosequencing: History, biochemistry and future [J].
Ahmadian, A ;
Ehn, M ;
Hober, S .
CLINICA CHIMICA ACTA, 2006, 363 (1-2) :83-94
[2]   Analysis of the p53 tumor suppressor gene by pyrosequencing [J].
Ahmadian, A ;
Lundeberg, J ;
Nyrén, P ;
Uhlén, M ;
Ronaghi, M .
BIOTECHNIQUES, 2000, 28 (01) :140-+
[3]  
Amedei A, 2001, EUR J IMMUNOL, V31, P1927, DOI 10.1002/1521-4141(200106)31:6<1927::AID-IMMU1927>3.0.CO
[4]  
2-D
[5]  
Aoshima M, 1996, BLOOD, V88, P1841
[6]   Photocleavage of a 2-nitrobenzyl linker bridging a fluorophore to the 5' end of DNA [J].
Bai, XP ;
Li, ZM ;
Jockusch, S ;
Turro, NJ ;
Ju, JY .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (02) :409-413
[7]   Genetic screening methods for the detection of mutations responsible for multiple endocrine neoplasia type 1 [J].
Balogh, K ;
Patócs, A ;
Majnik, J ;
Rácz, K ;
Hunyady, L .
MOLECULAR GENETICS AND METABOLISM, 2004, 83 (1-2) :74-81
[8]   Update on primary immunodeficiency diseases [J].
Bonilla, FA ;
Geha, RS .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) :S435-S441
[9]   Primary immunodeficiency or not? Making the correct diagnosis [J].
Buckley, RH .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (04) :756-758
[10]   Accessing genetic information with high-density DNA arrays [J].
Chee, M ;
Yang, R ;
Hubbell, E ;
Berno, A ;
Huang, XC ;
Stern, D ;
Winkler, J ;
Lockhart, DJ ;
Morris, MS ;
Fodor, SPA .
SCIENCE, 1996, 274 (5287) :610-614